(Q48032930)

7 February 2018

title

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area (English)

1 reference

7 February 2018

0 references

0 references

4

1 reference

7 February 2018

Sarah Gilbert

6

1 reference

7 February 2018

Kevin Marsh

8

object named as

Kevin Marsh

1 reference

7 February 2018

1

Philip Bejon

1 reference

7 February 2018

9

Adrian V S Hill

1 reference

7 February 2018

5

Trudie Lang

1 reference

7 February 2018

3

Jedidah Mwacharo

1 reference

7 February 2018

Oscar K Kai

2

object named as

Oscar K Kai

1 reference

7 February 2018

Norbert Peshu

7

object named as

Norbert Peshu

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 August 2006

1 reference

7 February 2018

European Journal of Immunology

published in

1 reference

7 February 2018

volume

36

1 reference

7 February 2018

issue

8

1 reference

7 February 2018

page(s)

2264-2272

1 reference

7 February 2018

The complexity of protective immunity against liver-stage malaria

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

T cells undergo rapid ON/OFF but not ON/OFF/ON cycling of cytokine production in response to antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

Common west African HLA antigens are associated with protection from severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

CD8+ T cell contraction is controlled by early inflammation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

A protein particle vaccine containing multiple malaria epitopes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636187

7 January 2021

Identifiers

DOI

10.1002/EJI.200636187

1 reference

7 February 2018

1 reference

7 February 2018